Google Alert - pharmaceutical news

News 10 new results for pharmaceutical news

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012 News-Medical.net Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced ... See all stories on this topic »

Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock ... Equities.com 28, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that its Board of Directors has adopted a policy to pay a regular quarterly dividend in such amounts as the Board of Directors may determine from time to time. See all stories on this topic »

TEXT-S&P rates Watson Pharmaceuticals notes 'BBB' Reuters Sept 27 - Standard & Poor's Ratings Services said today that it assigned Parsippany, N.J.-based generic pharmaceutical company Watson Pharmaceuticals Inc.'s $3.9 billion senior unsecured notes offering its 'BBB' issue-level rating. The company will ... See all stories on this topic »

Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in ... Equities.com 28, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) has opened enrollment in a phase 2 study in prostate cancer patients of its PSMA ADC compound. PSMA ADC is a targeted anti-cancer therapeutic that uses a monoclonal ... See all stories on this topic »

TEXT-Fitch cuts Watson Pharmaceuticals IDR to 'BBB-' Reuters The proposed acquisition of the Actavis Group, a privately-held global generic pharmaceutical company, for an upfront payment of EUR4.25 billion (approximately US$5.65 billion) plus additional consideration will drive up leverage to a level consistent ... See all stories on this topic »

Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride ... MENAFN.COM Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride for Injection, USP. SCHAUMBURG, Ill., Sep 28, 2012 (Menafn - GlobeNewswire via COMTEX) --Sagent Pharmaceuticals, Inc. SGNT today announced the launch of Vancomycin ... See all stories on this topic »

PAR PHARMACEUTICAL COMPANIES, INC. : Par Announces Completion Of ... 4-traders 28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This transaction has delivered significant value to our shareholders and is a strong endorsement of ... See all stories on this topic »

GoM finalises pricing policy for 348 drugs Economic Times NEW DELHI: The Group of Ministers (GoM) set up to determine the country's drug pricing policy will recommend that retail prices of 348 essential drugs be fixed at the weighted average price of brands that have more than 1% market share. This will lead ... See all stories on this topic » Economic Times

Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of ... Sacramento Bee 27, 2012 -- /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the U.S. Food and Drug Administration (FDA) approved Bayer's Stivarga® (regorafenib) tablets for the ... See all stories on this topic »

Drug makers gain; not too hurt by pricing cap Moneycontrol.com Reuters Market Eye - Shares in pharmaceutical companies gain despite a recommendation by a ministry panel to cap drug prices given the proposal is seen as less hurtful than expected. A panel of ministers recommended capping prices for 348 drugs ... See all stories on this topic » Moneycontrol.com

---

Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.